The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.…
350,375€
-0,86%
Echtzeit-Aktienkurs Vertex Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Vertex Pharmaceuticals Inc. Aktie
Vertex Pharmaceuticals: Kurszielsenkung
Charlotte (www.aktiencheck.de) - Rating-Update:
Die Analysten von BofA Securities bewerten die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Vertex is broadening its portfolio.…
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? @themotleyfool #stocks $VRTX $CRSP $ALPN
Vertex is broadening its portfolio.…
If Youd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Heres How Much Youd Have Today
Could Vertexs growth story continue?…
Vertex Pharmaceuticals: Hochstufung
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Evercore ISI stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807,…
Vertex Pharmaceuticals: Kursziel gesteigert
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von H.C. Wainwright & Co. bewerten die Aktie des US-Biotechkonzerns Vertex Pharmaceuticals Inc. (ISIN:…
Could This Stock Be the Next Biotech Buyout?
Vertex Pharmaceuticals $4.9 billion purchase of Alpine Immune Sciences probably wont be the last acquisition of a company focused on…
Could This Stock Be the Next Biotech Buyout? @themotleyfool #stocks $VERA $VRTX $ALPN
Vertex Pharmaceuticals $4.9 billion purchase of Alpine Immune Sciences probably wont be the last acquisition of a company focused on…
Vertex Pharmaceuticals: Alpine Accelerates Aspiration To Become Biotech Powerhouse
…
What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences
…
Jim Cramer shares his thoughts on Nike, Vertex Pharmaceuticals, CarMax, Airbnb, Visa and Mastercard
During the CNBC Investing Clubs Morning Meeting, Jim Cramer weighed in on the stock moves in Nike, Vertex Pharma and…
Vertex Pharmaceuticals: Buy, Sell, or Hold?
The stock hasnt made for a great buy this year, but is Vertex worth investing in for the long run?…
Vertex Pharmaceuticals: Buy, Sell, or Hold? @themotleyfool #stocks $VRTX
The stock hasnt made for a great buy this year, but is Vertex worth investing in for the long run?…
Vertex Pharmaceuticals: Übernahme von Alpine Immune Sciences - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Vertex Pharmaceuticals Inc.…
Milliarden-Deal! Ausgerechnet Vertex schlägt zu
Große Pharma- und Biotech-Unternehmen sind weiter auf der Suche nach aussichtsreichen Substanzen, um ihre Produktpipeline zu stärken. Der unangefochtene Weltmarktführer…
Milliarden-Deal! Ausgerechnet Vertex schlägt zu
Große Pharma- und Biotech-Unternehmen sind weiter auf der Suche nach aussichtsreichen Substanzen, um ihre Produktpipeline zu stärken. Der unangefochtene Weltmarktführer…
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion
…
Übernahme: Vertex Pharmaceuticals erwirbt Alpine Immune für Milliardensumme
Das biopharmazeutische Unternehmen will die Biotechfirma für rund 4,9 Milliarden Dollar übernehmen. Die Aktien von Alpine legten nachbörslich 36 Prozent…
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion
With the acquisition, Vertex will add Alpines portfolio of protein-based immunotherapies to treat autoimmune and inflammatory diseases.…
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion By Reuters
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion…
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 bln
Vertex Pharmaceuticals will acquire therapy developer Alpine Immune Sciences for $65 per share, or about $4.9 billion in cash, the…
Biotech Stocks: 5 Biggest Companies in 2024
What are the top biotech companies? The following five stocks have market capitalizations worth billions of dollars and operate in…
Vertex Pharmaceuticals: Ein führender Schmerzmediziner "bemerkenswert negativ" zu VX-548 - Aktienanalyse
Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets:
Die Analysten vom Investmenthaus RBC Capital Markets trauen der Aktie von Vertex…
Vertex Pharmaceuticals executive sells shares worth over $100k By Investing.com
Vertex Pharmaceuticals executive sells shares worth over $100k…
Vertex (VRTX) Continues to Diversify Beyond CF Franchise
While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of…
Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development
Vertex Pharmaceuticals (VRTX) plans to begin a phase I study on VX-407 in autosomal dominant polycystic kidney disease later this…
Vertex Pharmaceuticals: Diversifying Its Drug Portfolio For Future Growth
…
Forget Tesla, Buy This Magnificent Healthcare Stock Instead
Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.…
5 Small Biotech ETFs to Watch (Updated 2024)
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…
3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow
Vertex shares have climbed almost 50% over the past year.…
3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX $CRSP
Vertex shares have climbed almost 50% over the past year.…
The Zacks Analyst Blog Highlights JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies
JPMorgan Chase, Salesforce, Vertex Pharmaceuticals, Palo Alto Networks and The Williams Companies are part of the Zacks top Analyst Blog.…